COPTIC PHARMA

We are reducing risk by broadening and balancing our portfolio, diversifying into new product areas that show potential, while also fully capturing opportunities for our products across all geographic boundaries. Specifically, we expect to generate future sales growth by strengthening our core pharmaceuticals business and supplementing it with increased investment in growth areas such as vaccines, biopharmaceuticals and consumer healthcare. We are also seeking to unlock the geographic potential of our businesses, particularly in emerging markets. We have made good progress on this priorities , and we believe there remain many opportunities for Coptic Pharmaceuticals to diversify further... We recognize that we need to simplify our operating model further, changing the way we work, removing unnecessary processes and structures which slow us down and distract us from our mission.We believe it will radically change our business model giving us the capability to support a more diverse,..